CRISPR THERAPEUTIC revenue breakdown overview

CRISPR THERAPEUTIC revenue for the last year amounted to 33.89 M CHF, the most of which — 33.89 M CHF — came from its highest performing source at the moment, Gene-based Medicines, the year earlier bringing 312.53 M CHF. The greatest contribution to the revenue figure was made by Switzerland and United States — last year it brought CRISPR THERAPEUTIC 33.89 M CHF, and the year before that — 312.53 M CHF.